Planning Actively for Cancer Treatment (PACT) Act of 2013

HR 1801, Cancer Drug Coverage Parity Act/ S 1879 Cancer Treatment Parity Act HR 2477, Planning Actively for Cancer Treatment Act HR 2827, Part D Beneficiary Appeals Fairness Act HR 543, Blue Water Navy Vietnam Veterans Act HR 1491, Blue Water Navy Ship Accountability Act S 2844/HR 5503, James Zadroga 9/11 Health and Compensation Reauthorization Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801, Cancer Drug Coverage Parity Act/ S 1879 Cancer Treatment Parity Act HR 2477, Planning Actively for Cancer Treatment Act HR 2827, Part D Beneficiary Appeals Fairness Act HR 543, Blue Water Navy Vietnam Veterans Act HR 1491, Blue Water Navy Ship Accountability Act S 2844/HR 5503, James Zadroga 9/11 Health and Compensation Reauthorization Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801, Cancer Drug Coverage Parity Act/ S 1879 Cancer Treatment Parity Act HR 2477, Planning Actively for Cancer Treatment Act HR 2827, Part D Beneficiary Appeals Fairness Act HR 543, Blue Water Navy Vietnam Veterans Act HR 1491, Blue Water Navy Ship Accountability Act H.R. 5503, James Zadroga 9/11 Health and Compensation Reauthorization Act

Client expense: $63,500 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2477 Planning Actively for Cancer Treatment (PACT) Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Planning Actively for Cancer Treatment Act, HR 2477

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

HR 1801 Cancer Drug Coverage Parity Act / S 1879 Cancer Treatment Parity Act HR 2477 Planning Actively for Cancer Act HR 2827 Part D Beneficiary Appeals Fairness Act HR 543 Blue Water Navy Vietnam Veterans Act HR 1491 Blue Water Navy Ship Accountability Act

Client expense: $53,500 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801, Cancer Drug Coverage Parity Act/ S 1879 Cancer Treatment Parity Act HR 2477, Planning Actively for Cancer Treatment Act HR 2827, Part D Beneficiary Appeals Fairness Act HR 543, Blue Water Navy Vietnam Veterans Act HR 1491, Blue Water Navy Ship Accountability Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Establisment of Medicare cancer care planning service through the Planning Actively for Cancer Treatement (PACT) Act, H.R. 2477 SGR Repeal & Medicare Provider Payment Authorization Act of 2014, S 2000/HR 4015 Lobbying activities in House of Representatives and Senate

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services.Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act (HR 1146). Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for preserving access to radiation therapy services under the Medicare Physician Fee Schedule Support for repeal of Medicare sequestration cuts under the Budget Control Act of 2011 Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Support for H.R. 2477, the Planning Actively for Cancer Treatment (PACT) Act, to establish a new Medicare service for cancer care planning and coordination. Support for H.R. 2914, Promoting Integrity in Medicare Act of 2013, which amends title XVIII (Medicare) of the Social Security Act (SSA) with respect to the general exceptions to both ownership and compensation arrangement prohibitions against physician self-referrals of Medicare patients to the entity with which a physician has a certain financial relationship. Support for H.R. 2810, the Medicare Patient Access and Quality Improvement Act of 2013 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to: (1) repeal sustainable growth rate (SGR) methodology from the determination of annual conversion factors in the formula for payment for physicians' services; and (2) prescribe an update to the single conversion factor for 2014 through 2018, as well as 2019 all subsequent years, of 0.5%. Support the SGR repeal and Medicare Beneficiary Access Improvement Act of 2013

H.R. 1801, Cancer Drug Coverage Parity Act/S. 1879 Cancer Treatment Parity Act H.R. 2477, Planning Actively for Cancer Treatments Act H.R. 2827, Part D Beneficiary Appeals Fairness Act H.R. 543, Blue Water Navy Vietnam Veterans Act H.R. 1491, Blue Water Navy Ship Accountability Act

Client expense: $49,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Planning Actively for Cancer Treatment Act, HR 2477 SGR Repeal & Medicare Provider Payment Modernization Act of 2014, S 2000/HR 4015

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801, Cancer Drug Coverage Parity Act/ S. 1879 Cancer Treatment Parity Act HR 2477, Planning Actively for Cancer Treatment Act HR 2827, Part D Beneficiary Appeals Fairness Act HR 543 Blue Water Navy Vietnam Veterans ActHR 1491, Blue Water Navy Ship Accountability Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 800/S 806 To amend Part B of Title XVIII of the Social Security Act to exlude customary prompt pay discounts from manufacturers to wholesalers for the average sales price for drugs and biologicals under Medicare HR 1416 Cancer Patient Protection Act of 2013; HR 2477 The Planning Actively for Cancer Treatment (PACT) Act; HR 2810 Medicare Pateint Access and Quality Improvement Act of 2013; The SGR Repeal and Medicare Beneficiary Improvement Act

Client expense: $37,725 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1801, Cancer Drug Coverage Parity Act. S. 1879, Cancer Treatment Parity Act of 2013 H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 3680, Breast Cancer Awareness Commemorative Coin Act Pub. Law No. 113-54, Drug Quality and Security Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Cancer Drug Coverage Parity Act (H.R. 1801); Patients Access to Treatment Act (H.R. 460); Planning Activity for Cancer Treatment Act (H.R. 2477).

Client expense: Not reported · Firm income: $30,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2477, Planning Actively for Cancer Treatment Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services.Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act (HR 1146). Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for preserving access to radiation therapy services under the Medicare Physician Fee Schedule Support for repeal of Medicare sequestration cuts under the Budget Control Act of 2011 Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Support for H.R. 2477, the Planning Actively for Cancer Treatment (PACT) Act, to establish a new Medicare service for cancer care planning and coordination. Support for H.R. 2914, Promoting Integrity in Medicare Act of 2013, which amends title XVIII (Medicare) of the Social Security Act (SSA) with respect to the general exceptions to both ownership and compensation arrangement prohibitions against physician self-referrals of Medicare patients to the entity with which a physician has a certain financial relationship. Support for H.R. 2810, the Medicare Patient Access and Quality Improvement Act of 2013 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to: (1) repeal sustainable growth rate (SGR) methodology from the determination of annual conversion factors in the formula for payment for physicians' services; and (2) prescribe an update to the single conversion factor for 2014 through 2018, as well as 2019 all subsequent years, of 0.5%. Support the SGR repeal and Medicare Beneficiary Access Improvement Act of 2013

HR 1801, Cancer Drug Coverage Parity Act/S.1879, Cancer Treatment Parity Act HR 3204, Drug Quality and Security Act/S959, Pharmaceutical Quality, Security &Accountability HR 2477, Planning Actively for Cancer Treatment Act

Client expense: $47,500 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801, Cancer Drug Coverage Parity Act/ S. 1879 Cancer Treatment Parity Act HR 3204, Drug Quality & Security Act/S 959 Pharmaceutical Quality, Security & Accountability Act HR 2477, Planning Actively for Cancer Treatment Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Planning activity for Cancer Treatment Act (H.R. 2477); Comment Letter to CMS regarding Physician Fee schedule proposed rule; Comment Letter to CMS regarding Hospital Outpatient Prospective Payment System proposed rule.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Cancer Drug Coverage Parity Act (H.R. 1801); Patients Access to Treatment Act (H.R. 460); Planning Activity for Cancer Treatment Act (H.R. 2477).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

HR 800/S 806 To amend Part B of Title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare HR 1416 Cancer Patient Protection Act of 2013; HR 2477, The Planning Actively for Cancer Treatment (PACT) Act Issues related to the Sustainable Growth Rate. HR 2810 Medicare Patient Access and Quality Improvement Act of 2013

Client expense: $44,117 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 3204, Drug Quality and Security Act S. 957, Drug Supply Chain Security Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Improving Cancer Education Act (H.R. 1661); Planning Activity for Cancer Treatment Act (H.R. 2477)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES

HR 1801, Cancer Drug Coverage Parity Act HR 3204, Drug Quality & Security Act/S 959 Pharmaceutical Quality, Security & Accountability Act HR 2477, Planning Actively for Cancer Treatment Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1801, Cancer Drug Coverage Parity Act HR 3204, Drug Quality and Security Act/S 959, Pharmaceutical Quality, Security and Accountability Act HR 2477, Planning Actively for Canter Treatment Act

Client expense: $54,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services.Support for structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act (HR 1146). Support for repealing the establishment of an Independent Payment Advisory Board that would develop and submit detailed proposals to reduce the per capita rate of growth in Medicare spending, specifically the Medicare Decisions Accountability Act of 2011 (H.R. 452) (S 2118). Support for ensuring radiation oncologists participation in the Medicare electronic health record incentive program. Support for preserving access to radiation therapy services under the Medicare Physician Fee Schedule Support for repeal of Medicare sequestration cuts under the Budget Control Act of 2011 Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value. Support for H.R. 2477, the Planning Actively for Cancer Treatment (PACT) Act, to establish a new Medicare service for cancer care planning and coordination.

Client expense: $188,376 · Firm income: Not reported

H.R. 2477, the Planning Actively for Cancer Treatment Act (PACT Act)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1033 American Battlefield Protection Program Amendments Act of 2013 H.R.1434 Montana Land Sovereignty Act H.R.1439 Idaho Land Sovereignty ActH.R.1495 Arizona Land Sovereignty Act H.R.1512 New Mexico Land Sovereignty Act H.R.706 Blackstone River Valley National Historical Park Establishment Act H.R.138 Large Capacity Ammunition Feeding Device Act H.R.819 Preserving Access to Cape Hatteras National Seashore Recreational Area Act H.R.2497 Casa Grande Ruins National Monument Boundary Modification Act of 2013 H.R.2477 Planning Actively for Cancer Treatment (PACT) Act of 2013 H.R.716 To direct the Secretary of the Interior to convey certain Federal land to the city of Vancouver, Washington, and for other purposes. H.R.1513 To revise the boundaries of the Gettysburg National Military Park H.R.1208 Manhattan Project National Historical Park Act H.R.1158 North Cascades National Park Service Complex Fish Stocking Act H.R.2634 To modify the boundary of Petersburg National Battlefield in the Commonwealth of Virginia, and for other purposes H.R.1934 Saguaro National Park Boundary Expansion and Study Act of 2013 H.R.1785 Mountains to Sound Greenway National Heritage Area Act H.R.2015 Las Vegas Valley Public Land and Tule Springs Fossil Beds National Monument Act of 2013 H.R.586 Denali National Park Improvement Act H.R.1351 Public Lands Service Corps Act of 2013 H.R.2192 National Monument Designation Transparency and Accountability Act S.371 Blackstone River Valley National Historical Park Establishment Act S.916 American Battlefield Protection Program Amendments Act of 2013 S.150 Assault Weapons Ban of 2013 S.486 Preserving Public Access to Cape Hatteras Beaches Act S.1077 Chesapeake Bay Gateways and Watertrails Network Reauthorization Act S.476 A bill to amend the Chesapeake and Ohio Canal Development Act to extend to the Chesapeake and Ohio Canal National Historical Park Commission. S.644 PACT Act S.782 Gettysburg National Military Park Expansion Act S.507 Manhattan Project National Historical Park Act S.974 Las Vegas Valley Public Land and Tule Springs Fossil Beds National Monument Act of 2013 S.285 Valles Caldera National Preserve Management Act S.157 Denali National Park Improvement Act S.360 Public Lands Service Corps Act of 2013 No Legislation yet St. Louis Arch Access Pullman National Historical Park

H.R. 2477, Planning Actively for Cancer Treatment Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.

Client expense: $10,000 · Firm income: Not reported